Simultaneous Testing for 6 Lysosomal Storage Disorders and X-Adrenoleukodystrophy in Dried Blood Spots by Tandem Mass Spectrometry
Open Access
- 1 September 2016
- journal article
- Published by Oxford University Press (OUP) in Clinical Chemistry
- Vol. 62 (9) , 1248-1254
Abstract
BACKGROUND: Newborn screening for lysosomal storage disorders (LSD) has revealed that late-onset variants of these conditions are unexpectedly frequent and therefore may evade diagnosis. We developed an efficient and cost-effective multiplex assay to diagnose six LSDs and several peroxisomal disorders in patients presenting with diverse phenotypes at any age. METHODS: Three 3-mm dried blood spot (DBS) punches were placed into individual microtiter plates. One disc was treated with a cocktail containing acid sphingomyelinase-specific substrate and internal standard (IS). To the second DBS we added a cocktail containing substrate and IS for β-glucosidase, acid α-glucosidase, α-galactosidase A, galactocerebrosidase, and α-L-iduronidase. The third DBS was extracted with methanol containing d4-C26 lysophosphatidylcholine as IS and stored until the enzyme plates were combined and purified by liquid–liquid and solid-phase extraction. The extracts were evaporated, reconstituted with the extract from the lysophosphatidylcholine plate, and analyzed by flow injection tandem mass spectrometry. RESULTS: Reference intervals were determined by analysis of 550 samples from healthy controls. DBS from confirmed patients with 1 of the 6 LSDs (n = 33), X-adrenoleukodystrophy (n = 9), or a peroxisomal biogenesis disorder (n = 5), as well as carriers for Fabry disease (n = 17) and X-adrenoleukodystrophy (n = 5), were analyzed for assay validation. Prospective clinical testing of 578 samples revealed 25 patients affected with 1 of the detectable conditions. CONCLUSIONS: Our flow injection tandem mass spectrometry approach is amenable to high-throughput population screening for Hurler disease, Gaucher disease, Niemann–Pick A/B disease, Pompe disease, Krabbe disease, Fabry disease, X-adrenoleukodystrophy, and peroxisomal biogenesis disorder in DBS.Keywords
Funding Information
- Eunice Kennedy Shriver National Institute of Child Health and Human Development
- Foundation for the National Institutes of Health (HHSN275201000017C)
- Newborn Screening Translational Research Network (HHSN275200800001C 01)
- Mayo Clinic
- The Legacy of Angels Foundation
- GlaxoSmithKline
- Hunter's Hope Foundation
This publication has 19 references indexed in Scilit:
- Newborn screening for lysosomal storage disordersSeminars in Perinatology, 2015
- Newborn screening for X-linked adrenoleukodystrophy in New York State: Diagnostic protocol, surveillance protocol and treatment guidelinesMolecular Genetics and Metabolism, 2015
- Streamlined determination of lysophosphatidylcholines in dried blood spots for newborn screening of X-linked adrenoleukodystrophyMolecular Genetics and Metabolism, 2015
- Dried Blood Spot Quality Control Materials for Newborn Screening to Detect Lysosomal Storage DisordersClinical Chemistry, 2013
- Lysosomal storage disorder 4+1 multiplex assay for newborn screening using tandem mass spectrometry: Application to a small-scale population study for five lysosomal storage disordersClinica Chimica Acta, 2012
- Newborn screening for X-linked adrenoleukodystrophy (X-ALD): Validation of a combined liquid chromatography–tandem mass spectrometric (LC–MS/MS) methodMolecular Genetics and Metabolism, 2009
- Implementation of newborn screening for Krabbe disease: Population study and cutoff determinationClinical Biochemistry, 2009
- Development and Evaluation of Quality Control Dried Blood Spot Materials in Newborn Screening for Lysosomal Storage DisordersClinical Chemistry, 2009
- Multiplex Enzyme Assay Screening of Dried Blood Spots for Lysosomal Storage Disorders by Using Tandem Mass SpectrometryClinical Chemistry, 2008
- Direct Multiplex Assay of Lysosomal Enzymes in Dried Blood Spots for Newborn ScreeningClinical Chemistry, 2004